Guidelines for research involving recombinant DNA molecules.

The newest version of the “Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) is dated September 2009. In time, these Guidelines will be updated and the newest published version will dictate our College’s Guidelines for r-DNA research applications for approval where an IBC decision or input is mandated. The PI leading the research is responsible for reading the most recent Guidelines and implementing the required activities. When the Guidelines indicate that a r-DNA protocol must be registered and/or approved by the IBC, the PI must recognize this requirement, and file the r-DNA registration application materials. Note that Appendix B now terms Etiologic Agents by RISK GROUPS [RGs 1-4]. New emerging pathogens may be added in the future and these can be identified by going to http://oba.od.nih.gov/rdna/nih_guidelines_oba.html